Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neocytolysis in Renal Anemia with ESAs
NCT01306409Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2011
- Primary completion
- Jul 2011
- Modality
- Polymer-based Nanoparticles, Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta, darbepoetin alfa and epoetin beta in anemia of chronic kidney disease, sponsored by University Hospital Basel. Primary endpoint: Reticulocyte count on day 7. Started Jan 2011; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin betadarbepoetin alfaepoetin beta
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT01306409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01306409.